PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 44 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 163,538 | $1,636,000 | 0.09% |
Telemetry Investments, L.L.C. | 121,614 | $23,000 | 0.04% |
Radcliffe Capital Management, L.P. | 150,000 | $1,501,000 | 0.03% |
Q Global Advisors, LLC | 170,785 | $37,000 | 0.02% |
CANTOR FITZGERALD, L. P. | 363,548 | $79,000 | 0.01% |
Atalaya Capital Management LP | 225,000 | $50,000 | 0.01% |
MMCAP International Inc. SPC | 375,000 | $82,000 | 0.01% |
Bulldog Investors, LLP | 54,745 | $11,000 | 0.00% |
NEXPOINT ASSET MANAGEMENT, L.P. | 108,741 | $24,000 | 0.00% |
Context Capital Management, LLC | 200,000 | $44,000 | 0.00% |